The direct cost of epilepsy in children: Evidence from the Medical Expenditure Panel Survey, 2003–2014

Alain Lekoubou, Kinfe G. Bishu, Bruce Ovbiagele

Research output: Contribution to journalArticle

Abstract

Introduction: Epilepsy is frequent in children and often requires complex healthcare interventions. There is a paucity of recent and detailed healthcare expenditures among children with epilepsy in the United States (US). Methods: Data on children (aged ≤ 17 years) from the Medical Expenditure Panel Survey-Household Component (MEPS-HC) from 2003 to 2014 were analyzed. Unadjusted overall and specific cost components were compared between children with epilepsy and those without epilepsy. We used a two-part model with gamma distribution and log link for the estimation of independent incremental cost incurred by epilepsy in children. Unadjusted and adjusted mean expenditures and aggregate burden of epilepsy were estimated. Results: Out of 54,393,387 (weighted) US children, 457,873 (0.84%) had epilepsy. Children with epilepsy had nearly six times higher healthcare expenditure than those without epilepsy ($2024 [95% confidence interval (CI): 1917–2130] vs. $12,577 [95% CI: 7922–17,231]). Unadjusted inpatient expenditure for epilepsy ($4418 [95% CI: 1550–7285) was ten times higher than that for children without epilepsy, representing more than one-third of unadjusted total direct cost. The adjusted difference in medical expenditure between children with and those without epilepsy was $8317 (95% CI: 3701–13,363). The annual unadjusted aggregate cost of epilepsy in children was approximately $5.8 billion. The annual adjusted difference in cost of epilepsy between children with and those without epilepsy was $3.8 billion. Conclusion: Unadjusted and adjusted medical expenditure among children with epilepsy is high. The high expenditure is essentially driven not only by inpatient expenditure but also by home healthcare, outpatient, and medication healthcare expenditures.

Original languageEnglish (US)
Pages (from-to)103-107
Number of pages5
JournalEpilepsy and Behavior
Volume83
DOIs
StatePublished - Jun 2018

Fingerprint

Health Expenditures
Epilepsy
Costs and Cost Analysis
Delivery of Health Care
Confidence Intervals
Surveys and Questionnaires
Inpatients

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology
  • Behavioral Neuroscience

Cite this

@article{49b53ef1df6849db81df32a3c1184b9f,
title = "The direct cost of epilepsy in children: Evidence from the Medical Expenditure Panel Survey, 2003–2014",
abstract = "Introduction: Epilepsy is frequent in children and often requires complex healthcare interventions. There is a paucity of recent and detailed healthcare expenditures among children with epilepsy in the United States (US). Methods: Data on children (aged ≤ 17 years) from the Medical Expenditure Panel Survey-Household Component (MEPS-HC) from 2003 to 2014 were analyzed. Unadjusted overall and specific cost components were compared between children with epilepsy and those without epilepsy. We used a two-part model with gamma distribution and log link for the estimation of independent incremental cost incurred by epilepsy in children. Unadjusted and adjusted mean expenditures and aggregate burden of epilepsy were estimated. Results: Out of 54,393,387 (weighted) US children, 457,873 (0.84{\%}) had epilepsy. Children with epilepsy had nearly six times higher healthcare expenditure than those without epilepsy ($2024 [95{\%} confidence interval (CI): 1917–2130] vs. $12,577 [95{\%} CI: 7922–17,231]). Unadjusted inpatient expenditure for epilepsy ($4418 [95{\%} CI: 1550–7285) was ten times higher than that for children without epilepsy, representing more than one-third of unadjusted total direct cost. The adjusted difference in medical expenditure between children with and those without epilepsy was $8317 (95{\%} CI: 3701–13,363). The annual unadjusted aggregate cost of epilepsy in children was approximately $5.8 billion. The annual adjusted difference in cost of epilepsy between children with and those without epilepsy was $3.8 billion. Conclusion: Unadjusted and adjusted medical expenditure among children with epilepsy is high. The high expenditure is essentially driven not only by inpatient expenditure but also by home healthcare, outpatient, and medication healthcare expenditures.",
author = "Alain Lekoubou and Bishu, {Kinfe G.} and Bruce Ovbiagele",
year = "2018",
month = "6",
doi = "10.1016/j.yebeh.2018.03.020",
language = "English (US)",
volume = "83",
pages = "103--107",
journal = "Epilepsy and Behavior",
issn = "1525-5050",
publisher = "Academic Press Inc.",

}

The direct cost of epilepsy in children : Evidence from the Medical Expenditure Panel Survey, 2003–2014. / Lekoubou, Alain; Bishu, Kinfe G.; Ovbiagele, Bruce.

In: Epilepsy and Behavior, Vol. 83, 06.2018, p. 103-107.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The direct cost of epilepsy in children

T2 - Evidence from the Medical Expenditure Panel Survey, 2003–2014

AU - Lekoubou, Alain

AU - Bishu, Kinfe G.

AU - Ovbiagele, Bruce

PY - 2018/6

Y1 - 2018/6

N2 - Introduction: Epilepsy is frequent in children and often requires complex healthcare interventions. There is a paucity of recent and detailed healthcare expenditures among children with epilepsy in the United States (US). Methods: Data on children (aged ≤ 17 years) from the Medical Expenditure Panel Survey-Household Component (MEPS-HC) from 2003 to 2014 were analyzed. Unadjusted overall and specific cost components were compared between children with epilepsy and those without epilepsy. We used a two-part model with gamma distribution and log link for the estimation of independent incremental cost incurred by epilepsy in children. Unadjusted and adjusted mean expenditures and aggregate burden of epilepsy were estimated. Results: Out of 54,393,387 (weighted) US children, 457,873 (0.84%) had epilepsy. Children with epilepsy had nearly six times higher healthcare expenditure than those without epilepsy ($2024 [95% confidence interval (CI): 1917–2130] vs. $12,577 [95% CI: 7922–17,231]). Unadjusted inpatient expenditure for epilepsy ($4418 [95% CI: 1550–7285) was ten times higher than that for children without epilepsy, representing more than one-third of unadjusted total direct cost. The adjusted difference in medical expenditure between children with and those without epilepsy was $8317 (95% CI: 3701–13,363). The annual unadjusted aggregate cost of epilepsy in children was approximately $5.8 billion. The annual adjusted difference in cost of epilepsy between children with and those without epilepsy was $3.8 billion. Conclusion: Unadjusted and adjusted medical expenditure among children with epilepsy is high. The high expenditure is essentially driven not only by inpatient expenditure but also by home healthcare, outpatient, and medication healthcare expenditures.

AB - Introduction: Epilepsy is frequent in children and often requires complex healthcare interventions. There is a paucity of recent and detailed healthcare expenditures among children with epilepsy in the United States (US). Methods: Data on children (aged ≤ 17 years) from the Medical Expenditure Panel Survey-Household Component (MEPS-HC) from 2003 to 2014 were analyzed. Unadjusted overall and specific cost components were compared between children with epilepsy and those without epilepsy. We used a two-part model with gamma distribution and log link for the estimation of independent incremental cost incurred by epilepsy in children. Unadjusted and adjusted mean expenditures and aggregate burden of epilepsy were estimated. Results: Out of 54,393,387 (weighted) US children, 457,873 (0.84%) had epilepsy. Children with epilepsy had nearly six times higher healthcare expenditure than those without epilepsy ($2024 [95% confidence interval (CI): 1917–2130] vs. $12,577 [95% CI: 7922–17,231]). Unadjusted inpatient expenditure for epilepsy ($4418 [95% CI: 1550–7285) was ten times higher than that for children without epilepsy, representing more than one-third of unadjusted total direct cost. The adjusted difference in medical expenditure between children with and those without epilepsy was $8317 (95% CI: 3701–13,363). The annual unadjusted aggregate cost of epilepsy in children was approximately $5.8 billion. The annual adjusted difference in cost of epilepsy between children with and those without epilepsy was $3.8 billion. Conclusion: Unadjusted and adjusted medical expenditure among children with epilepsy is high. The high expenditure is essentially driven not only by inpatient expenditure but also by home healthcare, outpatient, and medication healthcare expenditures.

UR - http://www.scopus.com/inward/record.url?scp=85045618056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045618056&partnerID=8YFLogxK

U2 - 10.1016/j.yebeh.2018.03.020

DO - 10.1016/j.yebeh.2018.03.020

M3 - Article

C2 - 29684821

AN - SCOPUS:85045618056

VL - 83

SP - 103

EP - 107

JO - Epilepsy and Behavior

JF - Epilepsy and Behavior

SN - 1525-5050

ER -